Lipocine Inc. Files 2024 Annual Report
Ticker: LPCN · Form: 10-K · Filed: 2025-03-13T00:00:00.000Z
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Lipocine's 2024 10-K is in. Check financials and biz ops.
AI Summary
Lipocine Inc. filed its 10-K for the fiscal year ending December 31, 2024, reporting its financial position and business operations. The company, formerly known as Marathon Bar Corp, is incorporated in Delaware and operates in the pharmaceutical preparations sector. Its principal executive offices are located at 675 Arapeen Drive, Suite 202, Salt Lake City, Utah.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Lipocine's financial health and strategic direction for the past fiscal year, crucial for investment decisions.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Lipocine faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2023-12-31 — Prior Year End (Comparison point for financial data)
- 2022-12-31 — Year Before Prior (Further historical financial data)
Key Players & Entities
- Lipocine Inc. (company) — Filer of the 10-K
- Marathon Bar Corp (company) — Former name of Lipocine Inc.
- 2024-12-31 (date) — Fiscal year end
- 675 Arapeen Drive, Suite 202, Salt Lake City, Utah (location) — Business address
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What is the primary business of Lipocine Inc. as described in the 10-K?
Lipocine Inc. operates in the Pharmaceutical Preparations sector, SIC code 2834.
When is the fiscal year end for Lipocine Inc. according to this filing?
The fiscal year end is December 31, as indicated by the reporting period 20241231.
What was Lipocine Inc. formerly known as?
Lipocine Inc. was formerly known as Marathon Bar Corp, with a date of name change on 20111130.
Where is Lipocine Inc. headquartered?
Lipocine Inc.'s business and mail address is 675 Arapeen Drive, Suite 202, Salt Lake City, Utah.
What is the SEC file number for this 10-K filing?
The SEC file number for this 10-K filing is 001-36357.
From the Filing
0001493152-25-010146.txt : 20250313 0001493152-25-010146.hdr.sgml : 20250313 20250313093023 ACCESSION NUMBER: 0001493152-25-010146 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 83 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250313 DATE AS OF CHANGE: 20250313 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lipocine Inc. CENTRAL INDEX KEY: 0001535955 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 990370688 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36357 FILM NUMBER: 25734056 BUSINESS ADDRESS: STREET 1: 675 ARAPEEN DRIVE, SUITE 202 CITY: SALT LAKE CITY STATE: X1 ZIP: 84108 BUSINESS PHONE: 801 994 7383 MAIL ADDRESS: STREET 1: 675 ARAPEEN DRIVE, SUITE 202 CITY: SALT LAKE CITY STATE: X1 ZIP: 84108 FORMER COMPANY: FORMER CONFORMED NAME: MARATHON BAR CORP DATE OF NAME CHANGE: 20111130 10-K 1 form10-k.htm false FY 0001535955 P10Y 0001535955 2024-01-01 2024-12-31 0001535955 2024-06-28 0001535955 2025-03-11 0001535955 2024-12-31 0001535955 2023-12-31 0001535955 2023-01-01 2023-12-31 0001535955 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-12-31 0001535955 us-gaap:CommonStockMember 2022-12-31 0001535955 us-gaap:TreasuryStockCommonMember 2022-12-31 0001535955 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001535955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001535955 us-gaap:RetainedEarningsMember 2022-12-31 0001535955 2022-12-31 0001535955 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-12-31 0001535955 us-gaap:CommonStockMember 2023-12-31 0001535955 us-gaap:TreasuryStockCommonMember 2023-12-31 0001535955 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001535955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001535955 us-gaap:RetainedEarningsMember 2023-12-31 0001535955 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-01-01 2023-12-31 0001535955 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001535955 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-12-31 0001535955 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001535955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0001535955 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001535955 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2024-01-01 2024-12-31 0001535955 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0001535955 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-12-31 0001535955 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-12-31 0001535955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-12-31 0001535955 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-31 0001535955 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2024-12-31 0001535955 us-gaap:CommonStockMember 2024-12-31 0001535955 us-gaap:TreasuryStockCommonMember 2024-12-31 0001535955 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001535955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001535955 us-gaap:RetainedEarningsMember 2024-12-31 0001535955 LPCN:MajorCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-12-31 0001535955 LPCN:SingleCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember LPCN:VerityLicenseAgreementMember 2024-01-01 2024-12-31 0001535955 LPCN:VerityLicenseAgreementMember 2024-01-01 2024-12-31 0001535955 LPCN:AntaresLicenseAgreementMember 2023-01-01 2023-12-31 0001535955 us-gaap:OfficeEquipmentMember 2024-12-31 0001535955 us-gaap:ComputerEquipmentMember 2024-12-31 0001535955 us-gaap:FurnitureAndFixturesMember 2024-12-31 0001535955 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-12-31 0001535955 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0001535955 us-gaap:RestrictedStockMember 2024-01-01 2024-12-31 0001535955 us-gaap:Restri